Cancer, Epigenetics And The Nobel Prizes

The Nobel Prize in Physiology or Medicine 2012 have been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent” as it is described in the Nobel Prize web site. Professors Gurdon and Yamanaka have all the merits to be...

Descripción completa

Detalles Bibliográficos
Autor: Esteller, Manel, 1968-
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2012
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/123975
Acceso en línea:https://hdl.handle.net/2445/123975
Access Level:acceso abierto
Palabra clave:Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
id ES_cabdd6e2ffcd1863c1cd2d8e48af3670
oai_identifier_str oai:diposit.ub.edu:2445/123975
network_acronym_str ES
network_name_str España
repository_id_str
spelling Cancer, Epigenetics And The Nobel PrizesEsteller, Manel, 1968-Premis NobelCàncerEpigenèticaNobel PrizesCancerEpigeneticsThe Nobel Prize in Physiology or Medicine 2012 have been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent” as it is described in the Nobel Prize web site. Professors Gurdon and Yamanaka have all the merits to be bestowed with such a prestigious award for their seminal discoveries in the area. However, we can also consider this annual prize as a recognition to Epigenetics, similarly to the Nobel Prize of 2006 for Andrew Z. Fire and Craig C. Mello for their of RNA interference - gene silencing by doublestranded RNA. Reprogramming requires changing the epigenome of the cells and non-coding RNAs are critical elements in the establishment of epigenetic patternsElsevier Sci Ltd2012info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/123975Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1016/j.molonc.2012.10.004Molecular Oncology, 2012, Vol. 6, Issue 6, p. 565-566https://doi.org/10.1016/j.molonc.2012.10.004(c) Esteller, Manel, 2012info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1239752026-05-27T06:46:51Z
dc.title.none.fl_str_mv Cancer, Epigenetics And The Nobel Prizes
title Cancer, Epigenetics And The Nobel Prizes
spellingShingle Cancer, Epigenetics And The Nobel Prizes
Esteller, Manel, 1968-
Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
title_short Cancer, Epigenetics And The Nobel Prizes
title_full Cancer, Epigenetics And The Nobel Prizes
title_fullStr Cancer, Epigenetics And The Nobel Prizes
title_full_unstemmed Cancer, Epigenetics And The Nobel Prizes
title_sort Cancer, Epigenetics And The Nobel Prizes
dc.creator.none.fl_str_mv Esteller, Manel, 1968-
author Esteller, Manel, 1968-
author_facet Esteller, Manel, 1968-
author_role author
dc.subject.none.fl_str_mv Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
topic Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
description The Nobel Prize in Physiology or Medicine 2012 have been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent” as it is described in the Nobel Prize web site. Professors Gurdon and Yamanaka have all the merits to be bestowed with such a prestigious award for their seminal discoveries in the area. However, we can also consider this annual prize as a recognition to Epigenetics, similarly to the Nobel Prize of 2006 for Andrew Z. Fire and Craig C. Mello for their of RNA interference - gene silencing by doublestranded RNA. Reprogramming requires changing the epigenome of the cells and non-coding RNAs are critical elements in the establishment of epigenetic patterns
publishDate 2012
dc.date.none.fl_str_mv 2012
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/123975
url https://hdl.handle.net/2445/123975
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1016/j.molonc.2012.10.004
Molecular Oncology, 2012, Vol. 6, Issue 6, p. 565-566
https://doi.org/10.1016/j.molonc.2012.10.004
dc.rights.none.fl_str_mv (c) Esteller, Manel, 2012
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Esteller, Manel, 2012
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier Sci Ltd
publisher.none.fl_str_mv Elsevier Sci Ltd
dc.source.none.fl_str_mv Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419505911857152
score 15,300724